BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23246793)

  • 1. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
    Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
    Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
    Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
    Front Immunol; 2018; 9():322. PubMed ID: 29545790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
    Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
    Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer.
    Ren JG; Man QW; Zhang W; Li C; Xiong XP; Zhu JY; Wang WM; Sun ZJ; Jia J; Zhang WF; Zhao YF; Chen G; Liu B
    J Dent Res; 2016 Jan; 95(1):87-93. PubMed ID: 26124218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols.
    Chandler WL
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):125-32. PubMed ID: 23249614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-resolved calibration-free flow cytometric characterization of platelets and cell-derived microparticles in platelet-rich plasma.
    Konokhova AI; Chernova DN; Moskalensky AE; Strokotov DI; Yurkin MA; Chernyshev AV; Maltsev VP
    Cytometry A; 2016 Feb; 89(2):159-68. PubMed ID: 25808430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
    Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.